Recormon was given to 34 patients on hemodialysis. The drug's effects
on quality of life were judged by the results of clinical, laboratory,
experimental and psychological dynamic investigations. The highest ef
fect occurred on the therapy month 6-12. Recormon contributed to relie
f of asthenic and depressive syndromes, to an increase of activity and
improvement of well-being, quality of life by Karnofsky scale within
the first year of treatment. The dynamics of life quality changes depe
nded on initial psychophysical condition of the patients, the age, blo
od pressure, hematocrit. Recormon treatment is associated with the ris
k of euphoria.